GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (OTCPK:EDTXF) » Definitions » EV-to-Revenue

Spectral Medical (Spectral Medical) EV-to-Revenue : 80.67 (As of May. 26, 2024)


View and export this data going back to . Start your Free Trial

What is Spectral Medical EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Spectral Medical's enterprise value is $103.90 Mil. Spectral Medical's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $1.29 Mil. Therefore, Spectral Medical's EV-to-Revenue for today is 80.67.

The historical rank and industry rank for Spectral Medical's EV-to-Revenue or its related term are showing as below:

EDTXF' s EV-to-Revenue Range Over the Past 10 Years
Min: 8.41   Med: 35.84   Max: 113.32
Current: 82.2

During the past 13 years, the highest EV-to-Revenue of Spectral Medical was 113.32. The lowest was 8.41. And the median was 35.84.

EDTXF's EV-to-Revenue is ranked worse than
94.62% of 223 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.23 vs EDTXF: 82.20

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), Spectral Medical's stock price is $0.3687. Spectral Medical's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.01. Therefore, Spectral Medical's PS Ratio for today is 73.74.


Spectral Medical EV-to-Revenue Historical Data

The historical data trend for Spectral Medical's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spectral Medical EV-to-Revenue Chart

Spectral Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.46 43.19 25.36 59.23 77.60

Spectral Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.62 57.96 57.10 77.60 79.78

Competitive Comparison of Spectral Medical's EV-to-Revenue

For the Diagnostics & Research subindustry, Spectral Medical's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spectral Medical's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Spectral Medical's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Spectral Medical's EV-to-Revenue falls into.



Spectral Medical EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Spectral Medical's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=103.903/1.288
=80.67

Spectral Medical's current Enterprise Value is $103.90 Mil.
Spectral Medical's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Spectral Medical  (OTCPK:EDTXF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Spectral Medical's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.3687/0.005
=73.74

Spectral Medical's share price for today is $0.3687.
Spectral Medical's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Spectral Medical EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Spectral Medical's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Spectral Medical (Spectral Medical) Business Description

Traded in Other Exchanges
Address
135 - 2 The West Mall, Finance, Toronto, ON, CAN, M9C 1C2
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The company has one reporting segment Spectral Medical Inc. The Dialco Medical Inc. operations were considered discontinued by the company.